KRT16 and neoplasm: The up-regulation of KRT16 has been associated with higher tumor aggressiveness, acting as a positive regulator of cellular motility by reorganizing the actin cytoskeleton and in circulating tumor cells of metastatic breast cancer patients, associated with shorter relapse-free survival [58,59].